MRDN:NASDAQMeridian Holdings Inc. Analysis
Data as of 2026-05-22 - not real-time
$10.30
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Meridian Holdings posted a solid 17% year‑over‑year revenue increase in Q1 2026, driven by its B2B and B2C expansion, yet the company remains loss‑making with a -45.9% profit margin and negative EPS of -7.56. Operating cash flow of $22.8 M and free cash flow of $4.8 M provide some liquidity cushion, but the balance sheet shows a debt‑to‑equity ratio of 37.5 and total debt exceeding cash on hand. Technicals are mixed: the price sits just above the 20‑day SMA (10.49) and the 200‑day SMA (10.29), the RSI is neutral at 51.9, while the MACD histogram is negative and the signal line is bearish, suggesting limited upside momentum. Volatility is extreme at 154% over 30 days and beta is 1.42, indicating the stock moves sharply with the market and has a recent max drawdown of -73.6%. The DCF fair value of $9.85 is below the current price of $10.30, implying the stock is modestly overvalued, and the upside/downside metric of 91.6% reflects a substantial potential downside to the fair value. Support sits at $6.07 and resistance at $16.09, giving a wide trading range but limited near‑term catalyst. The gaming sector faces high regulatory scrutiny across the company’s diverse geographic footprint, adding to the overall risk profile. Despite strong top‑line growth, the negative profitability and high volatility temper enthusiasm. Investors should weigh the growth narrative against the substantial earnings deficits and market risk before taking a position.
Given the bearish MACD, decreasing volume trend, and price premium to intrinsic value, the short‑term outlook is cautious, while the medium‑term view hinges on the company’s ability to translate revenue growth into sustainable earnings. Long‑term prospects depend on successful navigation of regulatory environments and achieving operational leverage to improve margins.
Given the bearish MACD, decreasing volume trend, and price premium to intrinsic value, the short‑term outlook is cautious, while the medium‑term view hinges on the company’s ability to translate revenue growth into sustainable earnings. Long‑term prospects depend on successful navigation of regulatory environments and achieving operational leverage to improve margins.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Bearish MACD histogram and signal line
- Decreasing volume trend
- Current price above DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- 17% revenue growth YoY
- Negative profit margin and EPS
- High beta and volatility
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- Regulatory uncertainty in multiple jurisdictions
- Potential to improve margins with scale
- Elevated sector and liquidity risk
Key Metrics & Analysis
Financial Health
Revenue Growth17.30%
Profit Margin-45.94%
ROE-110.01%
ROA-0.42%
Debt/Equity37.46
P/B Ratio2.7
Op. Cash Flow$22.8M
Free Cash Flow$4.8M
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI51.9
Support$6.07
Resistance$16.09
MA 20$10.49
MA 50$8.69
MA 200$10.29
MACDBearish
VolumeDecreasing
Fear & Greed Index91.52
Valuation
Fair Value$9.85
Target Price$19.73
Upside/Downside91.59%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta1.42
Volatility153.88%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.